In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Myriad Genetics awarded US patent
Myriad Genetics is exclusive licensee of New Mayo Clinic patent on amyloid lowering drugs
IMI agrees license for colorectal cancer diagnostic
Maxim Pharmaceuticals licenses novel cancer therapeutic candidate to Myriad Genetics
Myriad Genetics acquires cancer drug
New Colon Cancer Gene Licensed Exclusively to Myriad Genetics
Genzyme Genetics licenses colon cancer diagnostic patent rights to LabCorp and Baylor
Genzyme Molecular Oncology licenses patent rights
AVANT agrees patent license for typhoid vaccine
Myriad Genetics Acquires Novel Therapeutic Drug Management Technology from Saladax Biomedical